Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SEPT6 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | FBXW7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | EMC4 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | PKDREJ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | PARP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | DCAF4L1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
mRNA | DDI2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CENPC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | DCAF10 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | HADH | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |